Claims
- 1. A film forming composition comprised of:
a) carrageenan; and b) sucralose.
- 2. The composition of claim 1, wherein the composition is substantially free of a film former or strengthening polymer.
- 3. The composition of claim 1, wherein the composition is comprised of, based upon the total dry weight of the composition,
a) from about 0.5 percent to about 20 percent of carrageenan; and b) from about 75 percent to about 99.5 percent of sucralose.
- 4. The composition of claim 1, wherein the composition is comprised of, based upon the total dry weight of the composition,
a) from about 5 percent to about 9 percent of carrageenan; and b) from about 83 percent to about 95 percent of sucralose.
- 5. The composition of claim 1, wherein the carrageenan is kappa carrageenan.
- 6. The composition of claim 1 further comprising, based upon the total dry weight of the composition, from about 0 to about 40 percent plasticizers.
- 7. The composition of claim 6 wherein the plasticizers are selected from the group consisting of polyethylene glycol, glycerol, sorbitol, sucrose, corn syrup, fructose, dioctyl-sodium sulfosuccinate, triethyl citrate, tribuyl citrate, 1,2-propylene glycol, mono acetate of glycerol, diacetate of glycerol, triacetate of glycerol, natural gums, and mixtures thereof.
- 8. The composition of claim 1 further comprising, based upon the total dry weight of the composition, from about 0 percent to about 14 percent of a coloring agent.
- 9. The composition of claim 8 wherein the coloring agent is selected from the group consisting of azo dyes, quinopthalone dyes, triphenylmethane dyes, xanthene dyes, indigoid dyes, iron oxides, iron hydroxides, titanium dioxide, natural dyes, and mixtures thereof.
- 10. A dosage form for delivering active agents comprising an outer coating, said outer coating comprising the composition of claim 1.
- 11. A pharmaceutical dosage form comprising an outer coating, said outer coating comprising the composition of claim 1.
- 12. The pharmaceutical dosage form of claim 11 further comprising a plurality of outer coatings, wherein at least a first portion of the dosage form is comprised of a first outer coating and at least a second portion of the dosage form is comprised of a second outer coating.
- 13. The pharmaceutical dosage form of claim 12 wherein the second outer coating is visually distinct from the first outer coating.
- 14. A pharmaceutical dosage form comprising a core, a subcoating substantially covers said core, and an outer coating substantially covers said subcoating, wherein the outer coating is comprised of the composition of claim 1.
- 15. The coated dosage form of claim 14 wherein the subcoating comprises cellulose ethers, plasticizers, polycarbohydrates, pigments, opacifiers, and mixtures thereof.
- 16. The dosage form of claim 1 having a surface gloss of at least about 150 gloss units.
- 17. The dosage form of claim 11 having a surface gloss of at least about 150 gloss units.
- 18. A tablet dip coated with the film forming composition according to claim 1.
- 19. The pharmaceutical dosage form of claim 11 comprising an effective amount of a pharmaceutical active ingredient, wherein said dosage form meets USP dissolution requirements for immediate release forms of said pharmaceutical active ingredient.
- 20. A dispersion comprised of the composition of claim 1 and a solvent.
- 21. The dispersion of claim 20 comprised of, based upon the total weight of the dispersion, from about 0.05% to about 5% of carrageenan, and from about 1% to about 30% of sucralose.
- 22. A method of making coated tablets comprising dip coating tablets with the aqueous dispersion of claim 20 under conditions sufficient.
- 23. A pharmaceutical dosage form comprising a core and a coating, said coating substantially covering said core and having a surface gloss of at least 150 when applied via dip coating to the core, wherein the coating comprises the composition of claim 1.
- 24. A simulated capsule-like medicament comprising:
a. a core having a first end and a second end, b. a first coating layer having a first visual distinction provided on said first end of said tablet core; c. a second coating layer having a second visual distinction on said second end of said tablet core wherein at least one of said first coating layer and second coating layer is comprised of the composition of claim 1.
- 25. The medicament of claim 24 having a surface gloss of at least about 150 gloss units.
- 26. The medicament of claim 24 wherein the second visual distinction is visually different from said first visual distinction.
- 27. The medicament of claim 26 wherein the first visual distinction is a first color, and the second visual distinction is a second color.
- 28. The medicament of claim 24 wherein at least one coating layer is comprised of, based upon the total dry weight of that coating layer,
a) from about 0.05 percent to about 20 percent of carrageenan; and b) from about 75 percent to about 99.5 percent of sucralose.
- 29. The medicament of claim 24 further comprising a subcoating layer substantially covering said core, said subcoating layer provided between said core and said first coating layer and said second coating layer.
- 30. The medicament of claim 29 wherein the subcoating comprises materials selected from the group consisting of cellulose ethers, plasticizers, polycarbohydrates, pigments, opacifiers, and mixtures thereof.
- 31. The film forming composition of claim 1 further comprising, based upon the total weight 35 of the composition, from about 0.001 percent to about 1 percent of a film former.
- 32. The film forming composition of claim 31 wherein the film former is selected from the group consisting of cellulose, starch, polyvinylpyrrolidone, derivatives and mixtures thereof.
- 33. The film forming composition of claim 1 comprising less than about 5% of cations, based upon the total weight of the film forming composition.
CROSS-REFERENCE TO RELATED APPLICATION
[0001] This Application claims the benefit of U.S. Application No. 60/325,727 filed on Sep. 28, 2001 (MCP 292), which is incorporated by reference in its entirety herein.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60325727 |
Sep 2001 |
US |